Open resources for chemical probes and their implications for future drug discovery.
Journal article
Balıkçı E. et al, (2023), Expert Opin Drug Discov, 18, 505 - 513
Discovery of a chemical probe to study implications of BPTF bromodomain inhibition in cellular and in vivo experiments.
Journal article
Martinelli P. et al, (2023), ChemMedChem
Cyclic peptides target the aromatic cage of a PHD-finger reader domain to modulate epigenetic protein function
Journal article
Coleman OD. et al, (2023), Chemical Science
Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4.
Journal article
Londregan AT. et al, (2022), J Med Chem
DNA double-strand break-derived RNA drives TIRR/53BP1 complex dissociation.
Journal article
Ketley RF. et al, (2022), Cell Rep, 41
Covalent fragment-based ligand screening approaches for identification of novel ubiquitin proteasome system modulators.
Journal article
Rothweiler EM. et al, (2022), Biol Chem
A chemical biology toolbox to investigate in-cell target engagement and specificity of PRMT5-inhibitors
Preprint
Rothweiler EM. et al, (2022)
Chemoproteomic Profiling of Covalent XPO1 Inhibitors to Assess Target Engagement and Selectivity.
Journal article
Martin JG. et al, (2021), Chembiochem, 22, 2116 - 2123
Fragment Screening Reveals Starting Points for Rational Design of Galactokinase 1 Inhibitors to Treat Classic Galactosemia.
Journal article
Mackinnon SR. et al, (2021), ACS Chem Biol, 16, 586 - 595
TP-MAP - an Integrated Software Package for the Analysis of 1D and 2D Thermal Profiling Data
Journal article
Feyertag F. and Huber KVM., (2021)
Assays to Characterize the Cellular Pharmacology of a Chemical Probe
Chapter
Stefaniak J. et al, (2021), DISCOVERY AND UTILITY OF CHEMICAL PROBES IN TARGET DISCOVERY, 16, 247 - 275
Deliberately Losing Control of C-H Activation Processes in the Design of Small-Molecule-Fragment Arrays Targeting Peroxisomal Metabolism.
Journal article
Khan Tareque R. et al, (2020), ChemMedChem, 15, 2513 - 2520
Discovery of novel immunopharmacological ligands targeting the IL-17 inflammatory pathway.
Journal article
Álvarez-Coiradas E. et al, (2020), Int Immunopharmacol, 89